What is it about?
This manuscript describes a method and provides an example of how to discover reagent antibodies very quickly using a novel commercially available technology platform. The particular antibodies described are used for developing assays that measure therapeutic proteins in patient serum.
Featured Image
Photo by Zoltan Tasi on Unsplash
Why is it important?
Rapid assay development that accelerates important therapies making it to market faster can have important impacts on treating human disease.
Perspectives
This manuscript is meant to be concise and simple to understand. It serves as the jumping off point for the development on this novel technology both inside Amgen and hopefully among other antibody discovery scientists in general.
Aaron Winters
Amgen Inc
Read the Original
This page is a summary of: Rapid single B cell antibody discovery using nanopens and structured light, mAbs, June 2019, Taylor & Francis,
DOI: 10.1080/19420862.2019.1624126.
You can read the full text:
Resources
Contributors
The following have contributed to this page
